Literature DB >> 7552895

Computer-assisted antimicrobial surveillance in a community teaching hospital.

E T Jozefiak1, J E Lewicki, W P Kozinn.   

Abstract

A computer-assisted, pharmacy-managed antimicrobial surveillance service is described. Rising drug costs and inappropriate use of antimicrobial drugs led to the January 1994 implementation of an antimicrobial surveillance program at a 369-bed community teaching hospital. A computer interface between the pharmacy and microbiology laboratory data-bases was established that allows pharmacists quick access to culture and susceptibility test results and provides timely reports identifying patients for whom intervention may be necessary. Pharmacists review the reports, assess the patient's condition, and, when appropriate, recommend changes in therapy to the prescribing physician. Data on interventions, costs, and outcomes are reviewed monthly. From January to July 1994, pharmacists monitored the antimicrobial therapy of 1384 patients. Interventions were recommended for 348 patients (25%). Physicians accepted 289 (83%) of the recommendations. The infection subsided in 280 (97%) of the patients for whom recommendations were accepted. The cost avoidance achieved by the interventions exceeded $32,000, which more than justified the one full-time pharmacist position assigned to the service. A computer-assisted antimicrobial surveillance service managed by pharmacists helped control costs and achieve favorable clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552895     DOI: 10.1093/ajhp/52.14.1536

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  3 in total

1.  Monitoring of antimicrobial therapy by an integrated computer program.

Authors:  S Grau; J Monterde; A Carmona; L Drobnic; E Salas; M Marín; D Campany; J Mateu
Journal:  Pharm World Sci       Date:  1999-08

2.  Improved antimicrobial interventions have benefits.

Authors:  J Barenfanger; M A Short; A A Groesch
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 3.  Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance.

Authors:  A G Carrie; G G Zhanel
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.